| Literature DB >> 31681749 |
Qiaofei He1, George N Bennett2, Ka-Yiu San3,2, Hui Wu1,4,5.
Abstract
Hydroxy fatty acids (HFAs) are valuable compounds that are widely used in medical, cosmetic and food fields. Production of ω-HFAs via bioconversion by engineered Escherichia coli has received a lot of attention because this process is environmentally friendly. In this study, a whole-cell bio-catalysis strategy was established to synthesize medium-chain ω-HFAs based on the AlkBGT hydroxylation system from Pseudomonas putida GPo1. The effects of blocking the β-oxidation of fatty acids (FAs) and enhancing the transportation of FAs on ω-HFAs bio-production were also investigated. When fadE and fadD were deleted, the consumption of decanoic acid decreased, and the yield of ω-hydroxydecanoic acid was enhanced remarkably. Additionally, the co-expression of the FA transporter protein, FadL, played an important role in increasing the conversion rate of ω-hydroxydecanoic acid. As a result, the concentration and yield of ω-hydroxydecanoic acid in NH03(pBGT-fadL) increased to 309 mg/L and 0.86 mol/mol, respectively. This whole-cell bio-catalysis system was further applied to the biosynthesis of ω-hydroxyoctanoic acid and ω-hydroxydodecanoic acid using octanoic acid and dodecanoic acid as substrates, respectively. The concentrations of ω-hydroxyoctanoic acid and ω-hydroxydodecanoic acid reached 275.48 and 249.03 mg/L, with yields of 0.63 and 0.56 mol/mol, respectively. This study demonstrated that the overexpression of AlkBGT coupled with native FadL is an efficient strategy to synthesize medium-chain ω-HFAs from medium-chain FAs in fadE and fadD mutant E. coli strains.Entities:
Keywords: AlkBGT; Escherichia coli; FadL; medium-chain fatty acids; ω-hydroxy fatty acids
Year: 2019 PMID: 31681749 PMCID: PMC6812396 DOI: 10.3389/fbioe.2019.00273
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Strains and plasmids.
| Wild-type | Laboratory collection | |
| Wild-type | Laboratory collection | |
| NH01 | W3110 Δ | This study |
| NH02 | W3110 Δ | This study |
| NH03 | W3110 Δ | This study |
| pBGT | pTrc99a carries | This study |
| pBGT- | pBGT carries | This study |
| pGRB | AmpR, bla, gRNA expression vector | Li et al., |
| pREDCas9 | SpeR, Cas9, λ Red recombinase expression vector | Li et al., |
Primers of plasmid and strain construction.
| ptrc99aF | CCATGGAATTCGAGCTCGGTAC |
| H-ptrc99aR | CTCCTTACCCTTTTTGCGAATTGTTATCCGC |
| AlkB-HF | CGCAAAAAGGGTAAGGAGGTATTATATGAATGG |
| AlkB-R | CTATGATGCTACCGCGGTTG |
| AlkG-HF | GCGGTAGCATCATAGCTACTATATAGAAAAGAGG |
| Alk-R | TTAGCCTAACTTTTCCTGATAGAGTACATAG |
| AlkT-HF | GAAAAGTTAGGCTAAACCTAATATAATTATTTTAAGGA |
| AlkT-R | GAGCTCGAATTCCATCTAATCAGGTAATT |
| pBGT-F | TCTAGAGTCGACCTGCAGGC |
| pBGT-R | GGATCCCCGGGTACCGAGC |
| FadL-F | AGCTCGGTACCCGGGGATCCTTGACAATTA |
| FadL-R | GCCTGCAGGTCGACTCTAGATCAGAACGCGTAG |
| FadE-SF | GCCTGCAGGTCGACTCTAGACCGCCGACCCAATT |
| FadE-SR | AGCTCGGTACCCGGGGATCCCTGATGAATTGGG |
| FadE-D1F | AGGTGGAGATCCCCAGCAGTAC |
| FadE-D1R | CTTTCGGCTCCGTTATTCATAACGAAAAGCC |
| FadE-D2F | CAAGTAAGGGGCTTTTCGTTATGAATAACG |
| FadE-D2R | CGTGTTATCGCCAGGCTTTAGG |
| FadD-SF | GCCTGCAGGTCGACTCTAGATCCAGTCT |
| FadD-SR | AGCTCGGTACCCGGGGATCCGCGGAAAG |
| FadD-D1F | AAGGGAAAACTCGCCTGGAA |
| FadD-D1R | TCTGACGACTGACTTAACGCTTCTTCAC |
| FadD-D2F | ATTTTAGAGGTGAAGAAGCGTTAAGT |
| FadD-D2R | TAACAGATACCAGACATCCGC |
Figure 1The simplified bioconversion pathways in the engineered E. coli strain.
Figure 2The effects of decanoic acid with differential status in the whole-cell bioconversion of W3110(pBGT) on the concentration (blue) and yield (orange) of ω-hydroxydecanoic acid production.
Figure 3The concentration (blue) and yield (orange) of ω-hydroxydecanoic acid produced by whole-cell conversion of W3110(pBGT) cultured with different concentrations of IPTG (A). The concentration (blue) and yield (orange) of ω-hydroxydecanoic acid produced at different temperatures by the whole-cell conversion of W3110(pBGT) cultured with 0.2 mM IPTG (B).
Figure 4Profiles of decanoic acid (C10FA) consumption and ω-hydroxydecanoic acid (C10HFA) accumulation in the whole-cell bioconversion of W3110(pBGT), NH01(pBGT), NH02(pBGT), NH03(pBGT), and NH03(pBGT-fadL). (A) The concentration of decanoic acid, (B) the concentration of ω-hydroxydecanoic acid. The summary of the concentration (blue) and yield (orange) of ω-hydroxydecanoic acid at the final time point in different engineered strains (C).
Figure 5Profiles of octanoic acid (C8FA) consumption and ω-hydroxy octanoic acid (C8HFA) accumulation in whole-cell bioconversion of NH03(pBGT-fadL) (A). Profiles of dodecanoic acid (C12FA) consumption and ω-hydroxy dodecanoic acid (C12HFA) accumulation in whole-cell bioconversion of NH03(pBGT-fadL) (B). Summary of the concentrations (blue) and yields (orange) of ω-hydroxyoctanoic acid and ω-hydroxydodecanoic acid at the final time point in NH03(pBGT-fadL) (C).